Hey I think Oncarlytics is an entirely different beast, who...

Hey I think Oncarlytics is an entirely different beast, who knows this may prove to be significant, still at early stages.

But re Azer Cell.
If the first line against DBCLB cures 60% of people (which it does).
And the third line - Azer Cell cures 57% of people (our current stats)
Im afraid it isn't enough for first line to be concerned, or to see it as a competitor. Azer Cell wont get moved up in line with those results.
It would need to do further trials against second line therapy (against Auto Car-Ts) later.

Perhaps, going against auto - Car T is where it is at, but this is much later on in the timeline. Perhaps in 18/24 months time. (post any registrational trial/commercialisation for 3rd in line), a Bp might see an opportunity for this allo Car -t to take some of the Auto Car -t therapy and fund it to go against 2nd in line therapies.

Again, Azer Cell, is good, (not great), but good for third line of therapy, at this particular moment. And I think it is important to have realistic timeline in-line with what is achievable.